Home > Healthcare > Medical Devices > Medical Equipment > Blood Processing and Storage Equipment Market

Blood Processing and Storage Equipment Market Share

Report ID: GMI4075
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Blood Processing and Storage Equipment Market Share

The blood processing and storage equipment industry is consolidated, with major players such as Becton, Dickinson, and Company (BD), and few others dominating the market. These companies are focused on continuous product innovation to secure a significant market share. In July 2021, BD stated that it had acquired Velano Vascular, a business that specialises in creating and manufacturing technologies for no-needle blood draws. The purchase is consistent with the company’s expansion strategy to enter various categories that address unmet needs and have a more favourable impact on patients and healthcare systems.

Some of the eminent market participants operating in the Blood processing and storage equipment market include:

Beckman Coulter, Inc.
Thermogenesis Holdings, Inc.
Maco Pharma International GmbH
Immucor, Inc.
Becton, Dickinson, and Company
Bio-Rad Laboratories, Inc.
Grifols, S.A.
Abbott Laboratories
Global Scientific Company
Sigma Laborzentrifugen GmbH
Terumo BCT, Inc.
Poly Medicure Ltd
Thermo Fisher Scientific, Inc.
Biomerieux
F. Hoffmann-La Roche Ltd

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market was valued at USD 44 billion in 2022 and is estimated to account for USD 87.6 billion by 2032, as these equipment are crucial components of healthcare systems and blood banks.

The devices segment garnered over USD 28 billion in the year 2022 as they are primarily used owing to their cost-efficiency, safety, accurate results, and ability to perform tasks with a high degree of precision.

U.S. blood processing and storage equipment market accounted for USD 16.6 billion in 2022 and is predicted to witness substantial growth through 2032, primarily due to the annual increase in the demand for blood components as well as alarming surge in cancer cases.

Immucor, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Grifols, S.A., Abbott Laboratories, Global Scientific Company, Sigma Laborzentrifugen GmbH, Terumo BCT, Inc., Poly Medicure Ltd., and Thermo Fisher Scientific, Inc. among others.